Lexicon Pharmaceuticals, Inc. (LXRX) CEO Lonnel Coats on Q1 2020 Results - Earnings Call Transcript [Seeking Alpha]
Lexicon Pharmaceuticals, Inc. (LXRX)
Last lexicon pharmaceuticals, inc. earnings: 4/27 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
lexpharma.com/investors
Company Research
Source: Seeking Alpha
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRXCompany ParticipantsDr. Kimberly Lee - Head, IR and Corporate StrategyLonnel Coats - President and CEOAlex Santini - EVP and Chief Commercial OfficerDr. Pablo Lapuerta - EVP and Chief Medical OfficerDr. Praveen Tyle - EVP, Research and DevelopmentJeff Wade - EVP, Corporate and Administrative Affairs and CFOConference Call ParticipantsYigal Nochomovitz - CitigroupLiana Moussatos - Wedbush SecuritiesStephen Willey - Stifel, Nicolaus & Co., Inc.Alan Carr - Needham & CompanyJessica Fye - JP Morgan Chase & Co.OperatorLadies and gentlemen, thank you for standing by and welcome to the Lexicon Pharmaceuticals First Quarter 2020 Financial Results and Business Update Call. [Operator Instructions] As a reminder, this call is being recorded today, April 27, 2020.I will now turn the call over to Dr. Kimberly Lee, Head of Investor Relations and Corporate Strategy. Please go ahead.Thank you. Good morning and welcome to the Lexicon Pharmaceuticals first quart
Show less
Read more
Impact Snapshot
Event Time:
LXRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LXRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LXRX alerts
High impacting Lexicon Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
LXRX
News
- Lexicon Pharmaceuticals Provides a Business and Pipeline Update at the 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewswire
- Lexicon Pharmaceuticals Publishes “Relief is Possible: Ensuring Access to Effective Treatments for Chronic Pain” [Yahoo! Finance]Yahoo! Finance
- Lexicon Pharmaceuticals Publishes “Relief is Possible: Ensuring Access to Effective Treatments for Chronic Pain” GlobeNewswire
- Lexicon Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewswire
- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) stock most popular amongst private equity firms who own 48%, while individual investors hold 27% [Yahoo! Finance]Yahoo! Finance
LXRX
Earnings
- 11/6/25 - Beat
LXRX
Sec Filings
- 11/10/25 - Form 8-K
- 11/6/25 - Form 424B5
- 11/6/25 - Form 8-K
- LXRX's page on the SEC website